A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world's deadliest infectious disease. Subscribe to our ...

A few weeks ago, we wrote about a positive test for latent tuberculosis and treating that infection with antibiotics. On the heels of that column, we received some follow-up questions from readers.

A study led by UT Southwestern Medical Center researchers has found that certain antibodies inhibit Mycobacterium ...

Spain-based Biofabri, the human vaccines subsidiary of the biopharmaceutical group Zendal, has added Rolando Pajón Feyt, an international expert in immunotherapy and vaccine development, to its ...

A team of scientists led by Oxford University have made a discovery that could improve our chances of developing an effective vaccine against Tuberculosis. The researchers have identified new ...

In the wake of a recent outbreak of tuberculosis (TB) and latent TB cases at a local San Francisco high school, IGHS's Priya ...

While all eyes have been focused on the race to develop a COVID-19 vaccine, other researchers have been furiously working on another way to defeat the coronavirus. It's a vaccine with a very long ...

CAMBRIDGE, MA -- A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world’s deadliest infectious disease. In the ...

A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world's deadliest infectious disease. In the new study, a team ...

More than 10,300 cases of tuberculosis were reported last year in the U.S., which is an 8% increase compared to 2023. What to ...

Though tuberculosis is rare in the United States as compared to developing countries, the region has some of the highest rates in the state.